Dopamine Deficiency Reduces Striatal Cholinergic Interneuron Function in Models of Parkinson’s Disease
暂无分享,去创建一个
Matthew Hur | Annie Vahedipour | M. Darvas | N. Bamford | A. Vahedipour | Martin Darvas | Jonathan W. McKinley | Ziqing Shi | Ivana Kawikova | Ian J. Bamford | Suma Priya Sudarsana Devi | Nigel S. Bamford | I. Kawikova | Matthew Hur | Ziqing Shi
[1] R. Palmiter,et al. Acetylcholine Encodes Long-Lasting Presynaptic Plasticity at Glutamatergic Synapses in the Dorsal Striatum after Repeated Amphetamine Exposure , 2013, The Journal of Neuroscience.
[2] Yvette E. Fisher,et al. Enhanced GABAergic Inputs Contribute to Functional Alterations of Cholinergic Interneurons in the R6/2 Mouse Model of Huntington’s Disease,, , 2015, eNeuro.
[3] S. Stoll,et al. Mechanism for the inhibition of the cAMP dependence of HCN ion channels by the auxiliary subunit TRIP8b , 2017, The Journal of Biological Chemistry.
[4] Charles J. Wilson,et al. Intrinsic Membrane Properties Underlying Spontaneous Tonic Firing in Neostriatal Cholinergic Interneurons , 2000, The Journal of Neuroscience.
[5] Pavel Osten,et al. HCN Channelopathy in External Globus Pallidus Neurons in Models of Parkinson’s Disease , 2010, Nature Neuroscience.
[6] R. Palmiter,et al. Relative contributions of severe dopaminergic neuron ablation and dopamine depletion to cognitive impairment , 2015, Experimental Neurology.
[7] Allan R. Jones,et al. A robust and high-throughput Cre reporting and characterization system for the whole mouse brain , 2009, Nature Neuroscience.
[8] J. Paul Bolam,et al. Extrinsic Sources of Cholinergic Innervation of the Striatal Complex: A Whole-Brain Mapping Analysis , 2016, Front. Neuroanat..
[9] A M Graybiel,et al. The basal ganglia and adaptive motor control. , 1994, Science.
[10] N. Cheviron,et al. Exploring the Regulation of the Expression of ChAT and VAChT Genes in NG108-15 Cells: Implication of PKA and PI3K Signaling Pathways , 2003, Neurochemical Research.
[11] O. Hornykiewicz,et al. Functional sensitization of striatal dopamine D1 receptors in the 6-hydroxydopamine-lesioned rat , 1992, Brain Research.
[12] Charles J. Wilson,et al. Spontaneous Activity of Neostriatal Cholinergic Interneurons In Vitro , 1999, The Journal of Neuroscience.
[13] R. Palmiter,et al. Dopamine Modulates Release from Corticostriatal Terminals , 2004, The Journal of Neuroscience.
[14] F. Horak,et al. Effects of a central cholinesterase inhibitor on reducing falls in Parkinson disease , 2010, Neurology.
[15] R. Wightman,et al. Dopamine’s Effects on Corticostriatal Synapses during Reward-Based Behaviors , 2018, Neuron.
[16] N. Bamford,et al. Regulation of prefrontal excitatory neurotransmission by dopamine in the nucleus accumbens core , 2012, The Journal of physiology.
[17] A. Graybiel,et al. Effect of the nigrostriatal dopamine system on acquired neural responses in the striatum of behaving monkeys. , 1994, Science.
[18] J. Caviness. Pathophysiology of Parkinson's disease behavior--a view from the network. , 2014, Parkinsonism & related disorders.
[19] P. Garris,et al. ‘Passive stabilization’ of striatal extracellular dopamine across the lesion spectrum encompassing the presymptomatic phase of Parkinson's disease: a voltammetric study in the 6‐OHDA‐lesioned rat , 2003, Journal of neurochemistry.
[20] Stefan Stoll,et al. Double electron–electron resonance reveals cAMP-induced conformational change in HCN channels , 2014, Proceedings of the National Academy of Sciences.
[21] R. Albin,et al. The cholinergic system and Parkinson disease , 2011, Behavioural Brain Research.
[22] Y. Kawaguchi,et al. Dopamine D1-Like Receptor Activation Excites Rat Striatal Large Aspiny Neurons In Vitro , 1998, The Journal of Neuroscience.
[23] C. Konradi,et al. Transcriptome analysis in a rat model of l-DOPA-induced dyskinesia , 2004, Neurobiology of Disease.
[24] M Abeles,et al. Activity of Pallidal and Striatal Tonically Active Neurons Is Correlated in MPTP-Treated Monkeys But Not in Normal Monkeys , 2001, The Journal of Neuroscience.
[25] J. Lechleiter,et al. Dopaminergic Neurons Exhibit an Age-Dependent Decline in Electrophysiological Parameters in the MitoPark Mouse Model of Parkinson's Disease , 2016, The Journal of Neuroscience.
[26] M. Zigmond,et al. Increased dopamine efflux from striatal slices during development and after nigrostriatal bundle damage , 1987, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[27] Xiaoli Wei,et al. Involvement of HCN Channel in Muscarinic Inhibitory Action on Tonic Firing of Dorsolateral Striatal Cholinergic Interneurons , 2016, Front. Cell. Neurosci..
[28] J. Wickens,et al. Pauses in cholinergic interneuron firing exert an inhibitory control on striatal output in vivo , 2018, eLife.
[29] C. Cepeda,et al. Repeated Exposure to Methamphetamine Causes Long-Lasting Presynaptic Corticostriatal Depression that Is Renormalized with Drug Readministration , 2008, Neuron.
[30] A. Beley,et al. Brain fixation for acetylcholine measurements , 1994, Journal of Neuroscience Methods.
[31] J. Lehmann,et al. The striatal cholinergic interneuron: Synaptic target of dopaminergic terminals? , 1983, Neuroscience.
[32] R. Palmiter,et al. Loss of glutamate signaling from the thalamus to dorsal striatum impairs motor function and slows the execution of learned behaviors , 2018, npj Parkinson's Disease.
[33] H. Lindgren,et al. A model of l-DOPA-induced dyskinesia in 6-hydroxydopamine lesioned mice: relation to motor and cellular parameters of nigrostriatal function , 2004, Neurobiology of Disease.
[34] E. Abercrombie,et al. Effects ofl-DOPA on extracellular dopamine in striatum of normal and 6-hydroxydopamine-treated rats , 1990, Brain Research.
[35] A. Colino,et al. ZD 7288 inhibits T-type calcium current in rat hippocampal pyramidal cells , 2008, Neuroscience Letters.
[36] Nicolas Maurice,et al. D2 Dopamine Receptor-Mediated Modulation of Voltage-Dependent Na+ Channels Reduces Autonomous Activity in Striatal Cholinergic Interneurons , 2004, The Journal of Neuroscience.
[37] Hui Zhang,et al. Heterosynaptic Dopamine Neurotransmission Selects Sets of Corticostriatal Terminals , 2004, Neuron.
[38] P Riederer,et al. Human brain D1 and D2 dopamine receptors in schizophrenia, Alzheimer's, Parkinson's, and Huntington's diseases. , 1987, Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology.
[39] P. Garris,et al. Dopamine release and uptake rates both decrease in the partially denervated striatum in proportion to the loss of dopamine terminals , 1997, Brain Research.
[40] E. Vaadia,et al. Coincident but Distinct Messages of Midbrain Dopamine and Striatal Tonically Active Neurons , 2004, Neuron.
[41] R. Spehlmann,et al. DOPAMINE ACETYLCHOLINE IMBALANCE IN PARKINSON'S DISEASE Possible Regenerative Overgrowth of Cholinergic Axon Terminals , 1976, The Lancet.
[42] S. A. O. Lim,et al. Enhanced striatal cholinergic neuronal activity mediates l-DOPA–induced dyskinesia in parkinsonian mice , 2010, Proceedings of the National Academy of Sciences.
[43] Antonio Pisani,et al. Acetylcholine-mediated modulation of striatal function , 2000, Trends in Neurosciences.
[44] Taro Kiritani,et al. Corticospinal-specific HCN expression in mouse motor cortex: I(h)-dependent synaptic integration as a candidate microcircuit mechanism involved in motor control. , 2011, Journal of neurophysiology.
[45] R. Burke,et al. Clinical progression in Parkinson disease and the neurobiology of axons , 2010, Annals of neurology.
[46] Charles J. Wilson,et al. The Cholinergic Interneurons of the Striatum: Intrinsic Properties Underlie Multiple Discharge Patterns , 2010 .
[47] J. Jankovic. Parkinson’s disease: clinical features and diagnosis , 2008, Journal of Neurology, Neurosurgery, and Psychiatry.
[48] R. Palmiter,et al. Cell-type-specific isolation of ribosome-associated mRNA from complex tissues , 2009, Proceedings of the National Academy of Sciences.
[49] C. Clarke,et al. MEDICAL MANAGEMENT OF PARKINSON'S DISEASE , 2002, Journal of neurology, neurosurgery, and psychiatry.
[50] H. Yonekawa,et al. Diphtheria toxin receptor–mediated conditional and targeted cell ablation in transgenic mice , 2001, Nature Biotechnology.
[51] Thomas D. Schmittgen,et al. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.
[52] R. Palmiter,et al. Contributions of signaling by dopamine neurons in dorsal striatum to cognitive behaviors corresponding to those observed in Parkinson's disease , 2014, Neurobiology of Disease.
[53] Xing Wu,et al. Is ZD7288 a selective blocker of hyperpolarization-activated cyclic nucleotide-gated channel currents? , 2012, Channels.
[54] D. Mash,et al. Dopamine D1 receptor expression in human basal ganglia and changes in Parkinson's disease , 2001 .
[55] S. Siegelbaum,et al. TRIP8b Regulates HCN1 Channel Trafficking and Gating through Two Distinct C-Terminal Interaction Sites , 2011, The Journal of Neuroscience.
[56] M. Zigmond,et al. Neurochemical compensation after nigrostriatal bundle injury in an animal model of preclinical parkinsonism. , 1984, Archives of neurology.
[57] S. Siegelbaum,et al. Molecular mechanism of cAMP modulation of HCN pacemaker channels , 2001, Nature.
[58] G. Snyder,et al. Dopamine efflux from striatal slices after intracerebral 6-hydroxydopamine: evidence for compensatory hyperactivity of residual terminals. , 1990, The Journal of pharmacology and experimental therapeutics.
[59] N. Bamford,et al. Nicotine Modifies Corticostriatal Plasticity and Amphetamine Rewarding Behaviors in Mice , 2016, eNeuro.
[60] Daniel S. McGehee,et al. Striatal cholinergic interneuron regulation and circuit effects , 2014, Front. Synaptic Neurosci..
[61] A. Barbeau. The pathogenesis of Parkinson's disease: a new hypothesis. , 1962, Canadian Medical Association journal.
[62] D. Surmeier,et al. D5 Dopamine Receptors Enhance Zn2+-Sensitive GABAA Currents in Striatal Cholinergic Interneurons through a PKA/PP1 Cascade , 1997, Neuron.
[63] M. Zigmond,et al. Tyrosine Hydroxylase Content of Residual Striatal Dopamine Nerve Terminals Following 6‐Hydroxydopamine Administration: A Flow Cytometric Study , 1989, Journal of neurochemistry.
[64] D. Haydon,et al. Ion transfer across lipid membranes in the presence of gramicidin A. II. The ion selectivity. , 1972, Biochimica et biophysica acta.
[65] S. Waxman. Transcriptional channelopathies: An emerging class of disorders , 2001, Nature Reviews Neuroscience.
[66] M. Albert,et al. CSF cyclic nucleotides and somatostatin in Parkinson's disease , 1986, Neurology.
[67] D. Sulzer,et al. How Addictive Drugs Disrupt Presynaptic Dopamine Neurotransmission , 2011, Neuron.
[68] T. Deguchi,et al. Transcriptional Regulation of Choline Acetyltransferase Gene by Cyclic AMP , 1993, Journal of neurochemistry.
[69] N. Bamford,et al. The Striatum’s Role in Executing Rational and Irrational Economic Behaviors , 2019, The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry.
[70] E. Benarroch. HCN channels , 2013, Neurology.
[71] R. Burke. Recent Advances in Research on Parkinson Disease: Synuclein and Parkin , 2004, The neurologist.
[72] T. Slotkin,et al. Effects of reserpine on the content and properties of rat adrenal medullary storage vesicles. , 1973, Biochemical pharmacology.
[73] Ted M. Dawson,et al. Genetic Animal Models of Parkinson's Disease , 2010, Neuron.